Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Regenevida
AddedFeb 16, 2024
UpdatedJun 18, 2026
Regenevida

Regenevida

Angel

Regenevida: Pioneering regenerative medicine with transplantable cells to improve human health.

HQ
Saint Paul, MN, US
Founded
2014
Overview
Compare
Fundraising
Employees
Website

Regenevida, a biotech company, focuses on developing transplantable cells, tissues, and organs to save lives. Founded with the mission to improve human health through advanced disease models and regenerative medicine, Regenevida leverages a visionary technology platform to address significant health threats. Their market focus includes individualized regenerative medicine solutions with real-world applications.

Notable affiliated individuals and investors include experts in biotechnology and regenerative medicine, though specific names are not provided. Key achievements involve pioneering advancements in transplantable regenerative products. The overall impact of Regenevida is significant, as it aims to revolutionize healthcare by providing innovative solutions to some of the most pressing medical challenges.

Regenevida - Similar Companies

Endogena Therapeutics logo

Endogena Therapeutics

Juventas Therapeutics logo

Juventas Therapeutics

juventasinc.com

Regenemed logo

Regenemed

regenemed.com

eGenesis logo

eGenesis

egenesisbio.com

iReprogram logo

iReprogram

ireprogram.com

Stemedica Cell Technologies logo

Stemedica Cell Technologies

stemedica.com

ReLive logo

ReLive

relivebio.com

Regenxbio logo

Regenxbio

regenxbio.com

Recombinetics logo

Recombinetics

recombinetics.com

Regennova logo

Regennova

regennova.com

Regenerative Medical Solutions logo

Regenerative Medical Solutions

Stemgenics logo

Stemgenics

stemgenics.com

Caeregen Therapeutics logo

Caeregen Therapeutics

caeregen.com

BioRegenx logo

BioRegenx

bioregenx.com

Hepatx logo

Hepatx

hepatx.com

Regenevida - Quick Facts

Who are Regenevida's competitors?

Companies similar to Regenevida include Endogena Therapeutics, Juventas Therapeutics, Regenemed and eGenesis.

When was Regenevida founded?

Regenevida was founded in 2014.

Where is Regenevida's headquarters located?

Regenevida's headquarters is located in Saint Paul, MN, US.

When was Regenevida's last funding round?

Regenevida's most recent funding round was for $7.4k (USD) in September 2018.

How much has Regenevida raised to-date?

As of Sep 6, 2018, Regenevida has raised a total of $7.4k (USD).

How many employees does Regenevida have?

Regenevida has 11 employees as of Feb 5, 2024.

Regenevida - Classification

Ownership
  • Venture Capital
Technology
  • Biotech
Geographic Exposure
  • Global
Model
  • Platform
Revenue
  • Recurring
  • Software
Customer
  • Enterprise
Main Product
  • Cell Therapy
  • Regenerative Medicine
Tags
  • Healthcare
  • Healthtech
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8730Research, Development, And Testing Services
  • 8731Commercial Physical and Biological Research
ISIC
  • 8690Other human health activities
Show 19 more industry codes
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 621000Ambulatory Health Care Services
  • 621500Medical and Diagnostic Laboratories
  • 621510Medical and Diagnostic Laboratories
  • 621511Medical Laboratories
  • 620000Health Care and Social Assistance
  • 325000Chemical Manufacturing
  • 623000Nursing and Residential Care Facilities
  • 325410Pharmaceutical and Medicine Manufacturing
  • 325412Pharmaceutical Preparation Manufacturing
SIC
  • 8070Medical And Dental Laboratories
  • 8071Medical Laboratories
  • 2800Chemicals And Allied Products
  • 8000Health Services
  • 2830Drugs
  • 8040Offices And Clinics Of Other Health Practitioners
  • 2834Pharmaceutical Preparations
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified